[INQ. NO. 2604E02] VIV Health is a startup developing wearable digital healthcare devices, offering personalized health-management solutions based on biosignal processing algorithms and AI-driven analytics.
The company has advanced its core technologies in collaboration with Professor Wonseok Jang (CSO) ― formerly of Samsung Medison and Siemens Medical R&D, and currently a professor in the Department of Medical Device Industry at Yonsei University College of Medicine.
VIV Health is continuing its research and development activities at the Seoul Biohub.
On February 5, 2026, the main functions of VIV Health’s smart ring, VIV™ Ring, were officially registered under the Ministry of Food and Drug Safety’s ‘Digital Medical & Health Support Device’ framework. This marks the first case in Korea of a wearable device ― specifically in smart ring form ― being registered under this system. The registration is significant in that the device’s intended purpose and functions have been formally recognized within the institutional regulatory framework established under Korea’s Digital Medical Products Act implemented last year.
Following Samsung Electronics’ prior registration of heart rate, blood oxygen saturation, and step-counting functions within the Samsung Health app, VIV Health completed registration for the smart ring hardware itself, thereby establishing a differentiated position in the hardware-based wearable market.

The VIV™ Ring is a titanium smart ring equipped with a high-precision PPG sensor and AI-based biosignal processing algorithms, designed for 24-hour continuous monitoring. It measures and analyzes key biosignals and activity data, including heart rate, blood oxygen saturation, and step count ― while also tracking sleep, stress, heart rate variability (HRV), and exercise data in an integrated manner. Through AI analysis, the device classifies user types and provides personalized health insights.
In addition, it includes a sleep-inducing sound feature aimed at improving the sleep environment, moving beyond simple measurement toward a preventive, lifestyle improvement-focused health management model. Users can automatically measure biosignals simply by wearing the device without manual operation, and receive alerts when abnormal signs are detected. Real-time measurement functions are also available when immediate status confirmation is needed.
VIV Health is targeting both B2C and B2B markets through a scalable revenue model that combines hardware with subscription-based (SaaS) services. In Korea, the company is pursuing collaborations with healthcare platform providers, major insurance companies, and construction firms. Overseas, it is expanding OEM agreements across the United States, the Middle East, Europe, Asia, and Latin America, pursuing a diversified global market strategy rather than focusing on a single country.
VIV Health’s last participation in KIMES 2026 served as a strategic entry point for expanding into the domestic market following MFDS registration. At the exhibition, VIV Health plans to directly introduce to medical professionals and industry stakeholders the upgraded UX/UI and the smart ring’s suitability and practical applications for measuring and analyzing biosignals to support medical care and maintain or enhance health.
VIV Health highlights the fact that many chronic conditions — such as obesity, dyslipidemia, diabetes, depression, and sleep disorders — are closely related to lifestyle habits. Given that daily management is critical, 24-hour monitoring through wearable devices can establish a new standard for preventive health management.
Through its smart ring, VIV Health aims to build a data-driven health management ecosystem and grow as a company that advances preventive, lifestyle-centered care models within the wearable digital healthcare sector.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods